27th International Congress on Cardiology and Medical Interventions July 31-01, 2019 Chicago, USA

Louis Samuels graduated Medical School from Hahnemann University (Philadelphia, PA) in 1987 and completed his Cardiothoracic Surgical training in 1995. He joined the faculty of Drexel University as the Surgical Director of Cardiac Transplantation. In 2001, Dr. Samuels and his team implanted the world’s 5th totally implantable electric artificial heart (AbioCor™). In 2003, he joined the Main Line Health System as the Surgical Director of Heart Failure. In addition to cardiac transplantation and LVAD implantation, Dr. Samuels performs CABG and Valvular surgery. In 2012, Dr. Samuels became Professor of Surgery at Thomas Jefferson University School of Medicine. Dr. Samuels has authored over 100 peer reviewed manuscripts and serves as a reviewer for the Annals of Thoracic Surgery.

His research interest are Annals of Thoracic Surgery, Cardiac Surgery.

Michael P. Savage is the Ralph J. Roberts Professor of Cardiology at Thomas Jefferson University and Director of the Cardiac Catheterization Laboratory at the Thomas Jefferson University Hospital in Philadelphia. He was instrumental in the formation of the recently opened Jefferson Angioplasty Center as a second-opinion center for high-risk patients with complex cardiovascular disease. The Jefferson team under Dr. Savage has pioneered many advances in interventional cardiology and was at the forefront of clinical research in the development of coronary stents that have revolutionized the treatment of heart disease. Dr. Savage's research continues to advance the care of cardiac patients by perfecting techniques for less invasive alternatives to heart surgery. His work includes over 230 publications of original research, book chapters, and abstracts. He has lectured nationally and internationally on a variety of cardiac disease topics and is an editorial consultant for numerous journals. He has received multiple honors for patient care, research, and teaching. Dr. Savage is a Fellow of the American College of Cardiology, the Society of Cardiac Angiography and Interventions, and the American College of Physicians..

His research interest are General/Preventative Cardiology - Interventional Cardiology

Christine Gasperetti is an interventional cardiologist with interests in high risk and protected coronary intervention as well as acute myocardial infarction. She has been involved in many studies of coronary artery disease and determinants of platelet function during coronary intervention. She is affiliated with the University of Pennsylvania Health System and works at several of their hospitals and affiliates.

Interventional Cardiology, Cardiac Catheterization,Preventive Cardiology,Cardiovascular Disease

Garber has over 32 years of experience in Internal Medicine and Cardiology, in addition to training, research, and development expertise in Regenerative Medicine. Over the past 12 years, he has made a significant contribution to stem cell research, specializing in the exploration and development of stem cell therapies for cardiac disorders, osteoarthritis, and neurological and autoimmune diseases. Formerly the Director of American Medical Information Group, he now serves as the Medical Director of Regenerative Medicine Madrid and the President of the Spanish Society of Regenerative Medicine and Cell Therapy (SEMERETEC). He also teaches a Master’s degree program in Regenerative Medicine and edits a number of scholarly journals on the subject.

Internal Medicine, Cardiology, Master in Health Administration and Body Damage Assessment, Master in Aesthetic Medicine

Salah A. Mohamed, Laboratory and Group Leader in Department of Cardiac and Thoracic Vascular Surgery, University Clinic of Schleswig-Holstein, Campus Luebeck in Germany, the group dedicated research interests to aortic and aortic valve diseases, Atrial fibrillation, aging, and biomarker. He has published more than 25 papers in reputed journals and has been serving as an editorial board member of repute.

Cardiovascular disease (e.g. genetic etiology and molecular), Epidemiology of aortic and aortic valve disease, Evaluation and validation of drugs and biomarkers, Aging of the heart

Bi-Hua Tan was initially trained as a cardiologist in China after graduated from medical school. Then she joined the arrhythmia and clinical electrophysiological study group at Cardiovascular Division, Hyogo College of Medicine in Japan and obtained her PhD degree there. After that she completed her postdoctoral training at the Cellular and Molecular Arrhythmia Research Program, Department of Medicine, University of Wisconsin-Madison. She was the first to characterize the molecular phenotype of eight common polymorphisms and some genetic basis of disease causing mutations in cardiac Na channel. She also first characterized a marked gain of functional KATPKir6.1 channel mutation in KCNJ8 as a novel pathogenic mechanism for the phenotypic expression of both Brugada syndrome and early repolarization syndrome. She was awarded American Heart Association (AHA) Postdoctoral Fellowship and the American Heart Association National Center Scientist Development Grant.

Cardiology, Cardiovascular Division